Seroprevalence of Human T-Cell Lymphoma/Leukemia Virus Type-1 (HTLV-1) Antibodies among Blood Donors at Ibadan, Nigeria

1Department of Haematology & Blood Transfusion, Gombe/ Gombe State University, Nigeria 2Department of Medical Microbiology, Gombe/Gombe State University, Nigeria 3Department of Medical Microbiology and Parasitology, University of Ibadan/University College Hospital Nigeria 4Institute of Child Health, College of Medicine University of Ibadan, Nigeria 5Department of Haematology, University of Ibadan/University College Hospital, Nigeria

[1]  B. Olusola,et al.  Seroprevalence of transfusion transmissible infections (TTI), in first time blood donors in Abeokuta, Nigeria. , 2015, African health sciences.

[2]  K. Jeang,et al.  Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy , 2011, Oncogene.

[3]  Aao Terry,et al.  Seroprevalence of HTLV -I/II amongst Blood Donors in Osogbo, Nigeria. , 2011 .

[4]  M. Muhibi,et al.  Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. , 2009, Blood transfusion = Trasfusione del sangue.

[5]  J. Barbara,et al.  The introduction of anti‐HTLV testing of blood donations and the risk of transfusion‐transmitted HTLV, UK: 2002–2006 , 2009, Transfusion medicine.

[6]  J. Forbi,et al.  Human T-cell lymphotropic virus in a population of pregnant women and commercial sex workers in South Western Nigeria. , 2007, African Health Sciences.

[7]  Y. Tettey,et al.  Seroprevalence of human T-cell lymphotropic virus type I among pregnant women in Accra, Ghana. , 2006, Journal of medical microbiology.

[8]  E. Murphy,et al.  Global epidemiology of HTLV-I infection and associated diseases , 2005, Oncogene.

[9]  R. Gallo.  History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2 , 2005, Oncogene.

[10]  C. Saura,et al.  Screening of blood donations for HTLV-I/II. , 1999, Transfusion medicine reviews.

[11]  C. Okany,et al.  Seroprevalence study of HTLV-1 and HIV infection in blood donors and patients with lymphoid malignancies in Lagos, Nigeria. , 1998, The Central African journal of medicine.

[12]  G. Whyte.  Is screening of Australian blood donors for HTLV‐I necessary? , 1997, Medical Journal of Australia.

[13]  S. Rasheed,et al.  Type-specific immune response to human T cell lymphotropic virus (HTLV) type I and type II infections in Nigeria. , 1994, The American journal of tropical medicine and hygiene.

[14]  R. Gallo,et al.  Frequency of adult T-cell leukaemia/lymphoma and HTLV-I in Ibadan, Nigeria. , 1993, British Journal of Cancer.

[15]  T. M. Hartley,et al.  Seroprevalence of HTLV-I and HTLV-II among Intravenous Drug Users and Persons in Clinics for Sexually Transmitted Diseases , 1992 .

[16]  M. Dumas,et al.  Seroepidemiology of human T-cell lymphotropic virus type I/II in Benin (West Africa). , 1991, AIDS research and human retroviruses.

[17]  W. Blattner,et al.  Licensure of screening tests for antibody to human T-lymphotropic virus type I. , 1988, MMWR. Morbidity and mortality weekly report.

[18]  A. Fleming,et al.  Antibodies to HTLV‐I in Nigerian blood‐donors, their relatives and patients with leukaemias, lymphomas and other diseases , 1986, International journal of cancer.

[19]  H. Nomura,et al.  Intrafamilial transmission of adult T cell leukemia virus. , 1986, The Journal of infectious diseases.

[20]  K. Okochi,et al.  A Retrospective Study on Transmission of Adult T Cell Leukemia Virus by Blood Transfusion: Seroconversion in Recipients , 1984, Vox sanguinis.